OL
IDXX icon

Optas LLC’s Idexx Laboratories IDXX Stock Holding History

Optas LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-588
Closed -$398K – 513
2025
Q4 		$398K Buy
+588
New +$400K 0.06% 220

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Optas LLC's IDXX Position: Q1 2026 in Review

Optas LLC sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 588 shares — an estimated $398K sold.

Optas LLC first reported a position in IDXX in Q4 2025 and held it in 1 quarter. The position peaked at $398K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Optas LLC reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Optas LLC sold 588 Idexx Laboratories shares in Q1 2026, an estimated $398K.
  • Optas LLC first reported a position in Idexx Laboratories in Q4 2025 and held it in 1 quarter.
  • Optas LLC's Idexx Laboratories position peaked at $398K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Optas LLC's 13F filing for Q1 2026, filed 27 Apr 2026.